Compound information
- Natural Products
- ZC1833394
- Molecular Formula
- C21H26N2O4
- Molecular Weight
- 370.189257312 g/mol
- Structure
-
- IUPAC Name
- benzyl (2R)-6-amino-2-(benzyloxycarbonylamino)hexanoate
- InChI
- InChI=1S/C21H26N2O4/c22-14-8-7-13-19(20(24)26-15-17-9-3-1-4-10-17)23-21(25)27-16-18-11-5-2-6-12-18/h1-6,9-12,19H,7-8,13-16,22H2,(H,23,25)/t19-/m1/s1
- InChI Key
- GCKQVXGRLKRLHJ-LJQANCHMSA-N
- SMILES
- NCCCC[C@@H](NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1
- Source
- ZINC000004899841
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 27 | Ring Count | 2 |
Heteroatom Count | 6 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 90.65 Å2 | LogP | 3.352 |
LogS | -3.049 | LogD | 3.042 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.05 | Pgp substrate | 0.77 |
HIA | 0.968 | F20 % | 0.924 |
F30 % | 0.002 | Caco-2 | -4.864 |
MDCK | -5.041 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.242 | PPB | 80.386 |
VD | 1.37 | Fu | 0.922 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.921 | CYP1A2 substrate | 0.793 |
CYP2A6 substrate | 0.515 | CYP2B6 substrate | 0.644 |
CYP2C19 inhibitor | 0.971 | CYP2C19 substrate | 0.723 |
CYP2C8 substrate | 0.83 | CYP2C9 inhibitor | 0.683 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.363 |
CYP2D6 substrate | 0.83 | CYP2E1 substrate | 0.378 |
CYP3A4 inhibitor | 0.8 | CYP3A4 substrate | 0.959 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.761 | CL | 3.138 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.953 | Hepatotoxicity | 0.215 |
Mutagenicity | 0.401 | Rat Oral Acute Toxicity | 0.186 |
FDAMDD | 0.415 | Skin Sensitization | 0.731 |
Carcinogenicity | 0.006 | Eye Corrosion | 0.003 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.077 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.28 | IGC50 | 4.216 |
LC50FM | 4.192 | LC50DM | 5.897 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.266 | NR-AR-LBD | 0.181 |
NR-AhR | 0.003 | NR-Aromatase | 0.055 |
NR-ER | 0.274 | NR-ER-LBD | 0.414 |
NR-PPAR-gamma | 0.257 | SR-ARE | 0.225 |
SR-ATAD5 | 0.394 | SR-HSE | 0.246 |
SR-MMP | 0.068 | SR-p53 | 0.046 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.